Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors.
Identifieur interne : 006A37 ( Main/Exploration ); précédent : 006A36; suivant : 006A38Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors.
Auteurs : S. Hayes [Australie] ; M. Janda ; B. Cornish ; D. Battistutta ; B. NewmanSource :
- Lymphology [ 0024-7766 ] ; 2008.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Lymphoedème.
- épidémiologie : Australie, Lymphoedème.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Prévalence, Tumeurs du sein.
- Wicri :
- geographic : Australie.
English descriptors
- KwdEn :
- MESH :
- geographic , epidemiology : Australia.
- complications : Breast Neoplasms.
- diagnosis : Lymphedema.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- Adult, Female, Humans, Middle Aged, Prevalence, Risk Factors.
Abstract
Research on secondary lymphedema primarily uses indirect methods for diagnosis. This paper compares prevalence and cumulative burden following breast cancer surgery, as well as personal, treatment, and behavioral characteristics associated with lymphedema, using different assessment techniques. Lymphedema status was assessed at three-monthly intervals between six- and 18-months post-surgery in a population-based sample of Australian women with recently diagnosed, unilateral, invasive breast cancer, using three methods: bioimpedance spectroscopy (BIS), difference between sum of arm circumferences (SOAC) and self-report. Depending on the method, point prevalence ranged between 8 to 28%, with 1 in 5 to 2 in 5 women experiencing lymphedema at some point in time. Of those with lymphedema defined by BIS, almost 40%-60% went undetected, and 40%-12% were misclassified as having lymphedema, based on self-report and SOAC, respectively. The choice of measure also had significant implications for identified risk factors. Over 10 characteristics were associated with lymphedema, however only one, experiencing other upper-body symptoms at baseline, influenced odds of lymphedema across all three methods. These findings highlight that secondary lymphedema poses a significant public health problem. Utilizing the most accurate and reliable method for assessment is crucial to advance our understanding of preventive and treatment strategies.
PubMed: 18581955
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003223
- to stream PubMed, to step Curation: 003223
- to stream PubMed, to step Checkpoint: 003223
- to stream Ncbi, to step Merge: 002D99
- to stream Ncbi, to step Curation: 002D99
- to stream Ncbi, to step Checkpoint: 002D99
- to stream Main, to step Merge: 006B39
- to stream Main, to step Curation: 006A37
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors.</title><author><name sortKey="Hayes, S" sort="Hayes, S" uniqKey="Hayes S" first="S" last="Hayes">S. Hayes</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Health and Biomedical Innovation, School of Public Health, Faculty of Health, Queensland University of Technology, Kelvin Grove, Australia. sc.hayes@qut.edu.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Institute of Health and Biomedical Innovation, School of Public Health, Faculty of Health, Queensland University of Technology, Kelvin Grove</wicri:regionArea><wicri:noRegion>Kelvin Grove</wicri:noRegion></affiliation></author><author><name sortKey="Janda, M" sort="Janda, M" uniqKey="Janda M" first="M" last="Janda">M. Janda</name></author><author><name sortKey="Cornish, B" sort="Cornish, B" uniqKey="Cornish B" first="B" last="Cornish">B. Cornish</name></author><author><name sortKey="Battistutta, D" sort="Battistutta, D" uniqKey="Battistutta D" first="D" last="Battistutta">D. Battistutta</name></author><author><name sortKey="Newman, B" sort="Newman, B" uniqKey="Newman B" first="B" last="Newman">B. Newman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18581955</idno><idno type="pmid">18581955</idno><idno type="wicri:Area/PubMed/Corpus">003223</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003223</idno><idno type="wicri:Area/PubMed/Curation">003223</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003223</idno><idno type="wicri:Area/PubMed/Checkpoint">003223</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003223</idno><idno type="wicri:Area/Ncbi/Merge">002D99</idno><idno type="wicri:Area/Ncbi/Curation">002D99</idno><idno type="wicri:Area/Ncbi/Checkpoint">002D99</idno><idno type="wicri:doubleKey">0024-7766:2008:Hayes S:lymphedema:secondary:to</idno><idno type="wicri:Area/Main/Merge">006B39</idno><idno type="wicri:Area/Main/Curation">006A37</idno><idno type="wicri:Area/Main/Exploration">006A37</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors.</title><author><name sortKey="Hayes, S" sort="Hayes, S" uniqKey="Hayes S" first="S" last="Hayes">S. Hayes</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Health and Biomedical Innovation, School of Public Health, Faculty of Health, Queensland University of Technology, Kelvin Grove, Australia. sc.hayes@qut.edu.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Institute of Health and Biomedical Innovation, School of Public Health, Faculty of Health, Queensland University of Technology, Kelvin Grove</wicri:regionArea><wicri:noRegion>Kelvin Grove</wicri:noRegion></affiliation></author><author><name sortKey="Janda, M" sort="Janda, M" uniqKey="Janda M" first="M" last="Janda">M. Janda</name></author><author><name sortKey="Cornish, B" sort="Cornish, B" uniqKey="Cornish B" first="B" last="Cornish">B. Cornish</name></author><author><name sortKey="Battistutta, D" sort="Battistutta, D" uniqKey="Battistutta D" first="D" last="Battistutta">D. Battistutta</name></author><author><name sortKey="Newman, B" sort="Newman, B" uniqKey="Newman B" first="B" last="Newman">B. Newman</name></author></analytic><series><title level="j">Lymphology</title><idno type="ISSN">0024-7766</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Australia (epidemiology)</term><term>Breast Neoplasms (complications)</term><term>Female</term><term>Humans</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (etiology)</term><term>Middle Aged</term><term>Prevalence</term><term>Risk Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Australie (épidémiologie)</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (épidémiologie)</term><term>Lymphoedème (étiologie)</term><term>Prévalence</term><term>Tumeurs du sein ()</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Australia</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Australie</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Prevalence</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Prévalence</term><term>Tumeurs du sein</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Australie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Research on secondary lymphedema primarily uses indirect methods for diagnosis. This paper compares prevalence and cumulative burden following breast cancer surgery, as well as personal, treatment, and behavioral characteristics associated with lymphedema, using different assessment techniques. Lymphedema status was assessed at three-monthly intervals between six- and 18-months post-surgery in a population-based sample of Australian women with recently diagnosed, unilateral, invasive breast cancer, using three methods: bioimpedance spectroscopy (BIS), difference between sum of arm circumferences (SOAC) and self-report. Depending on the method, point prevalence ranged between 8 to 28%, with 1 in 5 to 2 in 5 women experiencing lymphedema at some point in time. Of those with lymphedema defined by BIS, almost 40%-60% went undetected, and 40%-12% were misclassified as having lymphedema, based on self-report and SOAC, respectively. The choice of measure also had significant implications for identified risk factors. Over 10 characteristics were associated with lymphedema, however only one, experiencing other upper-body symptoms at baseline, influenced odds of lymphedema across all three methods. These findings highlight that secondary lymphedema poses a significant public health problem. Utilizing the most accurate and reliable method for assessment is crucial to advance our understanding of preventive and treatment strategies.</div></front></TEI><affiliations><list><country><li>Australie</li></country></list><tree><noCountry><name sortKey="Battistutta, D" sort="Battistutta, D" uniqKey="Battistutta D" first="D" last="Battistutta">D. Battistutta</name><name sortKey="Cornish, B" sort="Cornish, B" uniqKey="Cornish B" first="B" last="Cornish">B. Cornish</name><name sortKey="Janda, M" sort="Janda, M" uniqKey="Janda M" first="M" last="Janda">M. Janda</name><name sortKey="Newman, B" sort="Newman, B" uniqKey="Newman B" first="B" last="Newman">B. Newman</name></noCountry><country name="Australie"><noRegion><name sortKey="Hayes, S" sort="Hayes, S" uniqKey="Hayes S" first="S" last="Hayes">S. Hayes</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006A37 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006A37 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18581955
|texte= Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18581955" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |